A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder

Complementary Therapies in Medicine

Volumn 23, Issue 4, 2015, Pages 598-602

  Panahi, Yunes ^a   Badeli, Roghayeh ^b   Karami, Gholam Reza ^c   Badeli, Zeinab ^d   Sahebkar, Amirhossein ^e,f  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c University of Medical Sciences   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Anxiety; Chlorella vulgaris; Depression; Herbal Medicine; Microalgae; Randomized controlled trial

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOXIDANT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORELLA EXTRACT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; PLANT EXTRACT;

ADD ON THERAPY; ADULT; AGED; ANTIOXIDANT ACTIVITY; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DSM-IV; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; OPEN STUDY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG ADULT; CHLORELLA VULGARIS; DEPRESSIVE DISORDER, MAJOR; IRAN; MIDDLE AGED; PHYTOTHERAPY; PILOT STUDY; PSYCHOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; CHLORELLA VULGARIS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS;

EID: 84939145261     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2015.06.010     Document Type: Article

References (40)

1. Murray C.J.L., Lopez A.D. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020 1996, World Health Organization, Geneva, Switzerland.
2. Vos T., Flaxman A.D., Naghavi M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
3. Andrade L., Caraveo-Anduaga J.J., Berglund P., et al. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatry Res 2003, 12:3-21.
4. Nemeroff C.B. Prevalence and management of treatment-resistant depression. J Clin Psychiatry 2007, 68:s17-s25.
5. Khawam E., Laurencic G., Malone J.R.D. Side effects of antidepressants: an overview. Cleve Clin J Med 2006, 73:351-353.
6. Esmaily H., Sahebkar A., Iranshahi M., et al. An investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trial. Chinese J Integr Med 2015, 10.1007/s11655-015-2160-z.
7. Panahi Y., Badeli R., Karami G.R., Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother Res 2015, 29:17-21.
8. Solomon D., Adams J. The use of complementary and alternative medicine in adults with depressive disorders. a critical integrative review. J Affect Disord 2015, 179:101-113.
9. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
10. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
11. Cumurcu B.E., Ozyurt H., Etikan I., Demir S., Karlidag R. Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 2009, 63:639-645.
12. Gawryluk J.W., Wang J.F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 2011, 14:123-130.
13. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuroendocrinol Lett 2009, 30:462-469.
14. Behr G.A., Moreira J.C., Frey B.N. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev 2012, 2012:609421.
15. Chovanckova M., Simek V. Effects of high-fat and Chlorella vulgaris feeding on changes in lipid metabolism in mice. Biol Bratislava 2001, 56:661-666.
16. Panahi Y., Tavana S., Sahebkar A., Masoudi H., Madanchi N. Impact of adjunctive therapy with Chlorella vulgaris extract on antioxidant status, pulmonary function, and clinical symptoms of patients with obstructive pulmonary diseases. Sci Pharm 2012, 80:719-730.
17. Panahi Y., Ghamarchehreh M.E., Beiraghdar F., Zare M., Jalalian H.R., Sahebkar A. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepatogastroenterology 2012, 59:2099-2103.
18. Panahi Y., Mostafazadeh B., Abrishami A., et al. Investigation of the effects of Chlorella vulgaris supplementation on the modulation of oxidative stress in apparently healthy smokers. Clin Lab 2013, 59:579-587.
19. Vijayavel K., Anbuselvam C., Balasubramanian M.P. Antioxidant effect of the marine algae Chlorella vulgaris against naphthalene-induced oxidative stress in the albino rats. Mol Cell Biochem 2007, 303:39-44.
20. Wang H.M., Pan J.L., Chen C.Y., et al. Identification of anti-lung cancer extract from Chlorella vulgaris CC by antioxidant property using supercritical carbon dioxide extraction. Process Biochem 2010, 45:1865-1872.
21. Borowitzka M.A. Vitamins and fine chemicals from micro-algae. Micro-Algal Biotechnology 2015, 153. Cambridge University Press, New York. L.J. Borowitzka (Ed.).
22. Schubert L.E. The use of spirulina and Chlorella as food resource for animals and humans. Progressing Physiological Research 2015, 237. Biopress Ltd. F.E. Round, D.J. Chapman (Eds.).
23. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
24. Kaviani H., Seyfourian H., Sharifi V., Ebrahimkhani N. Reliability and validity of Anxiety and Depression Hospital Scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ Med J 2009, 67:379-385.
25. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
26. Dupont W.D., Plummer W.D. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998, 19:589-601.
27. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:664-675.
28. Lopresti A.L., Maker G.L., Hood S.D., Drummond P.D. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog Neuropsychopharmacol Biol Psychiatry 2014, 48:102-111.
29. Sano T., Tanaka Y. Effect of dried, powdered Chlorella vulgaris on experimental atherosclerosis and alimentary hypercholesterolemia in cholesterol-fed rabbits. Artery 1987, 14:76-84.
30. Shibata S., Natori Y., Nishihara T., et al. Antioxidant and anti-cataract effects of Chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol 2003, 49:334-339.
31. Sansawa H., Takahashi M., Tsuchikura S., Endo H. Effect of Chlorella and its fractions on blood pressure, cerebral stroke lesions, and life-span in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol 2006, 52:457-466.
32. Kim Y.J., Jeong S., Kwon S., Kim M.K. Effect of Chlorella vulgaris intake on antioxidative capacity in rats oxidatively stressed with dietary cadmium. Food Sci Biotechnol 2009, 18:1055-1062.
33. Nakashima Y., Ohsawa I., Konishi F., et al. Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice. Neurosci Lett 2009, 464:193-198.
34. Eyre H., Baune B.T. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012, 37:1397-1416.
35. Kanno T. The powerful medicinal Green Algea as a biological response modifier Chlorella vulgaris and Chlorella vulgaris extract (CVE) 2015, Woodland Publishing, Utah, USA.
36. Syed E., Wasay M., Awan S. Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial. Open Neurol J 2013, 7:44-48.
37. Inczedy-Farkas G., Remenyi V., Gal A. Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav Brain Funct 2012, 8:9.
38. Okuda M. Biological action of chlorella extract (3): preventive effect on induction of RD mutation and acceleration of cytochrome biosynthesis in yeast. J Med Soc Toho Jpn 1971, 18:743-750.
39. Okuda M., Takada H. Effect of extract of light-grown Chlorella cells on the induction of respiratory-deficient mutant of yeast by cationic surfactant. Boukinboubai 1975, 3:160-165.
40. Mizoguchi T., Takehara I., Masuzawa T., Saito T., Naoki Y. Nutrigenomic studies of effects of Chlorella on subjects with high-risk factors for lifestyle-related disease. J Med Food 2008, 11:395-404.